Neogenomics (NEO) Cash from Operations Growth (3y) (2013 - 2026)
Neogenomics (NEO) Cash from Operations Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | 17.81% |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | -12.11% |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | 13.13% |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | -11.38% |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | 14.01% |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | 35.64% |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | 206.88% |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | -3.02% |
| 10 | Neogenomics | 1.46 Bn | 1.32 Bn | 80.86 Mn | 13.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.77% |
| Dec 31, 2025 | 33.22% |
| Sep 30, 2025 | 36.55% |
| Jun 30, 2025 | 47.30% |
| Mar 31, 2025 | 4.46% |
| Dec 31, 2024 | 35.64% |
| Sep 30, 2024 | 47.21% |
| Jun 30, 2024 | 128.91% |
| Mar 31, 2024 | -139.43% |
| Dec 31, 2023 | 43.77% |
| Sep 30, 2023 | -131.77% |
| Jun 30, 2023 | -41.32% |
| Mar 31, 2023 | -22.33% |
| Dec 31, 2022 | -45.76% |
| Sep 30, 2022 | -42.16% |
| Jun 30, 2022 | -53.26% |
| Mar 31, 2022 | -89.11% |
| Dec 31, 2021 | -48.58% |
| Sep 30, 2021 | -43.04% |
| Jun 30, 2021 | -30.24% |